Literature DB >> 17525955

Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity.

Eliza Congdon1, Klaus Peter Lesch, Turhan Canli.   

Abstract

Impulsivity, a highly prevalent symptom in multiple psychiatric disorders, is a partially heritable trait influenced by specific biological mechanisms. In particular, dopamine is proposed to play a role in impulsive behaviors and recent studies have implicated functional polymorphisms of dopamine-related genes in impulsive behaviors across different clinical and behavioral classifications. However, most have not isolated the impulsivity construct per se as a biologically based and measurable endophenotype. The present study was therefore undertaken in a sample of healthy adults to investigate the influence of two candidate dopaminergic gene polymorphisms (DRD4 and DAT) on the endophenotype of impulsivity, which we operationalized as behavioral inhibition during the Stop-signal task. We recruited an ethnically diverse sample of 119 healthy adults to complete a self-report questionnaire of impulsivity and to perform a Stop-signal task. We report significant differences in inhibitory control between individuals with at least one 7-repeat allele of the DRD4 polymorphism, as well as an interaction between DRD4 and DAT genotypes, on inhibitory control. Results of the present study support the influence of dopaminergic variation on impulsive-related measures, as well as the advantage of using measures which are likely more sensitive to the effects of such genetic variation. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17525955     DOI: 10.1002/ajmg.b.30557

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  81 in total

1.  Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans.

Authors:  Dara G Ghahremani; Buyean Lee; Chelsea L Robertson; Golnaz Tabibnia; Andrew T Morgan; Natalie De Shetler; Amira K Brown; John R Monterosso; Adam R Aron; Mark A Mandelkern; Russell A Poldrack; Edythe D London
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

Review 2.  Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition.

Authors:  Adam R Aron; Sarah Durston; Dawn M Eagle; Gordon D Logan; Cathy M Stinear; Veit Stuphorn
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

3.  DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues.

Authors:  F Joseph McClernon; Kent E Hutchison; Jed E Rose; Rachel V Kozink
Journal:  Psychopharmacology (Berl)       Date:  2007-07-05       Impact factor: 4.530

Review 4.  CNTRICS final task selection: executive control.

Authors:  Deanna M Barch; Todd S Braver; Cameron S Carter; Russell A Poldrack; Trevor W Robbins
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

5.  Potential contribution of dopaminergic gene variants in ADHD core traits and co-morbidity: a study on eastern Indian probands.

Authors:  Subhamita Maitra; Kanyakumarika Sarkar; Paramita Ghosh; Arijit Karmakar; Animesh Bhattacharjee; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Cell Mol Neurobiol       Date:  2014-03-02       Impact factor: 5.046

Review 6.  Cognitive neuroscience of Attention Deficit Hyperactivity Disorder: current status and working hypotheses.

Authors:  Chandan J Vaidya; Melanie Stollstorff
Journal:  Dev Disabil Res Rev       Date:  2008

7.  Dopamine receptor D4 (DRD4) gene modulates the influence of informational masking on speech recognition.

Authors:  Zilong Xie; W Todd Maddox; Valerie S Knopik; John E McGeary; Bharath Chandrasekaran
Journal:  Neuropsychologia       Date:  2014-12-11       Impact factor: 3.139

8.  Increased brain activity to unpleasant stimuli in individuals with the 7R allele of the DRD4 gene.

Authors:  Jean-G Gehricke; James M Swanson; Sophie Duong; Jenny Nguyen; Timothy L Wigal; James Fallon; Cyrus Caburian; Lutfi Tugan Muftuler; Robert K Moyzis
Journal:  Psychiatry Res       Date:  2014-11-04       Impact factor: 3.222

9.  Do genetic and individual risk factors moderate the efficacy of motivational enhancement therapy? Drinking outcomes with an emerging adult sample.

Authors:  Sarah W Feldstein Ewing; Heather A LaChance; Angela Bryan; Kent E Hutchison
Journal:  Addict Biol       Date:  2009-03-05       Impact factor: 4.280

10.  Association of a monoamine oxidase-a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder.

Authors:  Jasmin Roohi; Carla J DeVincent; Eli Hatchwell; Kenneth D Gadow
Journal:  J Autism Dev Disord       Date:  2008-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.